Loblaw refreshes pet food line as analysts rate Loblaw stock Moderate Buy

Published on 10/08/2026 at 16:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

PC Nutrition First prices are up to 40.00 percent lower per 100g. Loblaw stock costs EUR 39.40 on October 8, 2026 with bid EUR 39.00.

Key points in brief

Loblaw refreshed its PC Nutrition First pet food line with prices up to 40.00 percent lower per 100g.
Eight brokerages gave Loblaw a Moderate Buy consensus on October 2, 2026.
Second-quarter revenue rose 4.10 percent to CAD 15.30 billion, while adjusted earnings per share rose 11.90 percent.
Loblaw stock was trading at EUR 39.40 at Lang & Schwarz on October 8, 2026 at 4:36 p.m. CEST.

Loblaw, CA5394811015, Illustration mit AI erstellt.

Loblaw (ISIN CA5394811015) was trading at EUR 39.40 at Lang & Schwarz on October 8, 2026 at 4:36 p.m. CEST. The company refreshed its PC Nutrition First pet food line, while a Moderate Buy consensus covered the stock.

Three dated operating signals

On October 8, 2026, Simply Wall St reported that Loblaw had refreshed PC Nutrition First recipes for dogs and cats, with prices up to 40.00 percent lower per 100g than comparable specialty-store products.

On September 9, 2026, the company presented an adjusted diluted net earnings per common share growth framework of 8.00 percent to 10.00 percent annually, while complementary businesses were expected to contribute 10.00 percent of operating income in 2026, according to GlobeNewswire.

On July 30, 2026, second-quarter revenue including PC Financial reached CAD 15.30 billion, up 4.10 percent, while adjusted diluted net earnings per common share rose 11.90 percent to CAD 0.66, Yahoo Finance reported.

What does the refresh change?

The pet-food update extends Loblaw's value strategy into a category where price and quality compete directly. Simply Wall St noted that the line is designed to reinforce private-label appeal across grocery, pharmacy and household shopping, while pricing scrutiny and margin pressure remain the key counter-factors.

The second-quarter figures show why this strategy matters financially. Drug retail sales increased 6.10 percent and online sales rose 19.30 percent during the second quarter of 2026, giving Loblaw several growth channels beyond conventional grocery.

Next reporting date

Loblaw's next substantiated reporting date is November 19, 2026, when it plans to release third-quarter results, according to the July 30 earnings call transcript. The investor calendar lists the September 9, 2026 Investor Day and July 30, 2026 second-quarter call as completed events.

Stock valuation and trading

Loblaw had a market capitalization of CAD 73.0 billion and a 52-week range of CAD 54.44 to CAD 69.59 as of October 8, 2026. The Lang & Schwarz quote stood below the upper end of that Canadian range in a separate currency context, so the comparison is descriptive rather than a calculated euro distance.

The further course of trading is shown by the continuously updated real-time quote of Loblaw stock.